Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News NY Valves 2025

Promising Early Data With Navitor TAVI Valves

Yael L. Maxwell

July 02, 2025

Presentation NY Valves 2025

Outcomes of TEE vs. ICE-guided Left Atrial Appendage Closure Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 26, 2025

Presentation NY Valves 2025

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 25, 2025

Presentation NY Valves 2025

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Jeremiah P. Depta

June 25, 2025

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

Presentation NY Valves 2024

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Presenter: Azeem Latib

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

Presenter: Charles J. Davidson

June 06, 2024

Presentation NY Valves 2024

TRILUMINATE: Looking Beyond the Headlines – What Lessons Have We Learned?

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

Case Presentation 1: T-TEER With TriClip in a Patient With Atrial Functional TR

Presenter: Matthew J. Price

June 06, 2024

Presentation NY Valves 2024

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

Presenter: Jörg Hausleiter

June 05, 2024

Video

» On Record

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

August 6, 2025

Advertisement

Promising Early Data With Navitor TAVI Valves

Outcomes of TEE vs. ICE-guided Left Atrial Appendage Closure Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Outcomes of Same-day vs. Delayed Discharge After LAAC Using a Fluoropolymer Coated Device: HEAL-LAA Post Approval Study Sub-analysis

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

TRISCEND II: Understanding the Study Design and Interpreting the Results

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

TRILUMINATE: Looking Beyond the Headlines – What Lessons Have We Learned?

Case Presentation 1: T-TEER With TriClip in a Patient With Atrial Functional TR

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

On Record: How the FDA Approval of Asymptomatic TAVI Has Changed Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content